The Z-Lig is the first engineered biologic device for treatment of revision and multiligament anterior cruciate ligament knee reconstruction to be granted a CE Mark.
Aperion Biologics is a privately owned, medical device company focused on addressing the need for alternatives to human-based grafts with animal-based tissue technology.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.